Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Asthma and COPID: differences and similarities - With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort (R)) in both diseases

Decramer, M and Selroos, Olof LU (2005) In International Journal of Clinical Practice 59(4). p.385-398
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) both have a high prevalence worldwide and yet each condition remains underdiagnosed. Despite a number of common features, these inflammatory respiratory syndromes have distinct clinical outcomes. COPD represents a greater economic burden than asthma because it has a less favourable prognosis and is associated with greater morbidity and mortality. Therefore, it is important to distinguish between these two diseases at an early stage, so that appropriate therapy can be prescribed to prevent deterioration. However, effective treatments that may be used in both conditions can minimise the effects of misdiagnosis and maximise the impact of treatment without the associated complexity when... (More)
Asthma and chronic obstructive pulmonary disease (COPD) both have a high prevalence worldwide and yet each condition remains underdiagnosed. Despite a number of common features, these inflammatory respiratory syndromes have distinct clinical outcomes. COPD represents a greater economic burden than asthma because it has a less favourable prognosis and is associated with greater morbidity and mortality. Therefore, it is important to distinguish between these two diseases at an early stage, so that appropriate therapy can be prescribed to prevent deterioration. However, effective treatments that may be used in both conditions can minimise the effects of misdiagnosis and maximise the impact of treatment without the associated complexity when both conditions occur together. The current review summarises the differences and similarities of asthma and COPD, in terms of risk factors, pathophysiology, symptoms and diagnosis, to provide greater understanding of the role of budesonide/ formoterol in a single inhaler in both diseases. (Less)
Please use this url to cite or link to this publication:
author
and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
budesonide, formoterol, COPD, asthma, comparison
in
International Journal of Clinical Practice
volume
59
issue
4
pages
385 - 398
publisher
Wiley-Blackwell
external identifiers
  • pmid:15853852
  • wos:000228062100004
  • scopus:16344381709
ISSN
1742-1241
DOI
10.1111/j.1368-5031.2005.00509.x
language
English
LU publication?
yes
id
fdc95a2c-37d6-4e16-bba0-3f1c9b89cdf2 (old id 247076)
date added to LUP
2016-04-01 16:13:31
date last changed
2022-01-28 18:12:13
@article{fdc95a2c-37d6-4e16-bba0-3f1c9b89cdf2,
  abstract     = {{Asthma and chronic obstructive pulmonary disease (COPD) both have a high prevalence worldwide and yet each condition remains underdiagnosed. Despite a number of common features, these inflammatory respiratory syndromes have distinct clinical outcomes. COPD represents a greater economic burden than asthma because it has a less favourable prognosis and is associated with greater morbidity and mortality. Therefore, it is important to distinguish between these two diseases at an early stage, so that appropriate therapy can be prescribed to prevent deterioration. However, effective treatments that may be used in both conditions can minimise the effects of misdiagnosis and maximise the impact of treatment without the associated complexity when both conditions occur together. The current review summarises the differences and similarities of asthma and COPD, in terms of risk factors, pathophysiology, symptoms and diagnosis, to provide greater understanding of the role of budesonide/ formoterol in a single inhaler in both diseases.}},
  author       = {{Decramer, M and Selroos, Olof}},
  issn         = {{1742-1241}},
  keywords     = {{budesonide; formoterol; COPD; asthma; comparison}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{385--398}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{International Journal of Clinical Practice}},
  title        = {{Asthma and COPID: differences and similarities - With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort (R)) in both diseases}},
  url          = {{http://dx.doi.org/10.1111/j.1368-5031.2005.00509.x}},
  doi          = {{10.1111/j.1368-5031.2005.00509.x}},
  volume       = {{59}},
  year         = {{2005}},
}